Acetazolamide recalls

The FDA has published 3 recalls involving Acetazolamide since 2012. The latest was reported on 25 Sep 2024. Most were for sterility. Rubicon Research Private has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls3since 2012

Last 12 months0reported

Class I00% of total

Ongoing1latest 25 Sep 2024

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 2 67%Class III 1 33%

Why acetazolamide is recalled

Companies

By year

2024133%
2021133%
2012133%

Ongoing acetazolamide recalls

1 active

Reported	Class	Recall	Company	Reason	Where
25 Sep 2024Drug	CLASS III	AcetaZOLAMIDE Tablets, USP, 125 mg bottled recalledAcetazolamide	Rubicon Research Private	Other	Nationwide

All acetazolamide recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
25 Sep 2024Drug	CLASS III	AcetaZOLAMIDE Tablets, USP, 125 mg bottled recalledAcetazolamide	Rubicon Research Private	Other	Nationwide
2 Jun 2021Drug	CLASS II	AcetaZOLAMIDE Tablets, USP 125 mg recalled by Cardinal HealthAcetazolamide	Cardinal Health	Manufacturing (CGMP) Deviations	FL, GA, SC
22 Aug 2012Drug	CLASS II	Acetazolamide, Lyophilized 500mg Injectable10 Vial, 4 Vial recalled	Franck's Lab Inc., d.b.a. Franck's Compounding Lab	Sterility	Nationwide

Should you stop taking Acetazolamide?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.